Liu et al.'s study compared adiponectin levels in patients with type 2 diabetes mellitus with cognitive impairment and those with normal cognitive function, and data showed that adiponectin levels were significantly reduced in patients with cognitive impairment [22]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.